Are you looking to meet with all the key decision makers in the covalent space, including CXOs, VPs and Directors of Medicinal, Discovery, and Biological Chemistry?
With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for
